| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.09 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.073 | 0.09 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.09 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.09 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.09 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.09 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.25 | 0.09 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.09 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.09 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.1 |